Preferential binding of growth inhibitory prostaglandins by the target protein of a carcinogen - PubMed (original) (raw)

Preferential binding of growth inhibitory prostaglandins by the target protein of a carcinogen

S H Khan et al. Proc Natl Acad Sci U S A. 1990 Dec.

Abstract

Liver fatty acid binding protein (L-FABP) is the principal target protein of the hepatic carcinogen N-(2-fluorenyl)acetamide (2-acetylaminofluorene) in rat liver. In addition, the cyclopentenone prostaglandins (PG), PGA, PGJ2, and delta 12-PGJ2, inhibit the growth of many cell types in vitro. This report describes the preferential binding of the growth inhibitory prostaglandins by L-FABP and the reversible inhibition of thymidine incorporation into DNA by PGA2 and delta 12-PGJ2 in primary cultures of purified rat hepatocytes. As a model ligand, [3H]PGA1 bound to L-FABP specifically, reversibly, rapidly, and with high affinity. Its dissociation constants were 134 nM (high affinity) and 3.6 microM (low affinity). The high-affinity binding of [3H]PGA1 was 9- and approximately 13-fold more avid than the binding of the conventional fatty acid ligands, oleic acid and arachidonic acid, respectively. The abilities of different prostaglandins to compete with the high-affinity binding of [3H]PGA1 correlated with their growth inhibitory activities reported previously and here. The growth inhibitory cyclopentenone prostaglandins (PGA1, PGA2, delta 12-PGJ2, and PGJ2) were the best competitive ligands, intermediate competitors were the weak growth inhibitors PGE1 and PGD2, and the poorest competitors were PGE2 and PGF2 alpha, which stimulate rather than inhibit DNA synthesis in rat hepatocytes in primary culture. The in vitro actions of L-FABP are compatible with those of a specific and dissociable carrier of growth inhibitory prostaglandins in rat hepatocytes and suggest that the carcinogen may usurp the cellular machinery of the growth inhibitory prostaglandins.

PubMed Disclaimer

Similar articles

• Modulation of mitogenesis by liver fatty acid binding protein.
  Sorof S. Sorof S. Cancer Metastasis Rev. 1994 Dec;13(3-4):317-36. doi: 10.1007/BF00666102. Cancer Metastasis Rev. 1994. PMID: 7712594 Review.
• Specific high affinity binding of lipoxygenase metabolites of arachidonic acid by liver fatty acid binding protein.
  Raza H, Pongubala JR, Sorof S. Raza H, et al. Biochem Biophys Res Commun. 1989 Jun 15;161(2):448-55. doi: 10.1016/0006-291x(89)92619-3. Biochem Biophys Res Commun. 1989. PMID: 2500117
• Liver fatty acid binding protein is the mitosis-associated polypeptide target of a carcinogen in rat hepatocytes.
  Bassuk JA, Tsichlis PN, Sorof S. Bassuk JA, et al. Proc Natl Acad Sci U S A. 1987 Nov;84(21):7547-51. doi: 10.1073/pnas.84.21.7547. Proc Natl Acad Sci U S A. 1987. PMID: 3478711 Free PMC article.
• Specific growth stimulation by linoleic acid in hepatoma cell lines transfected with the target protein of a liver carcinogen.
  Keler T, Barker CS, Sorof S. Keler T, et al. Proc Natl Acad Sci U S A. 1992 Jun 1;89(11):4830-4. doi: 10.1073/pnas.89.11.4830. Proc Natl Acad Sci U S A. 1992. PMID: 1594582 Free PMC article.
• Cyclopentenone prostaglandins: new insights on biological activities and cellular targets.
  Straus DS, Glass CK. Straus DS, et al. Med Res Rev. 2001 May;21(3):185-210. doi: 10.1002/med.1006. Med Res Rev. 2001. PMID: 11301410 Review.

Cited by

• Expression in Escherichia coli and characterization of the fatty-acid-binding protein from human muscle.
  Peeters RA, Ena JM, Veerkamp JH. Peeters RA, et al. Biochem J. 1991 Sep 1;278 ( Pt 2)(Pt 2):361-4. doi: 10.1042/bj2780361. Biochem J. 1991. PMID: 1898327 Free PMC article.
• Induction by prostaglandin A1 of haem oxygenase in myoblastic cells: an effect independent of expression of the 70 kDa heat shock protein.
  Rossi A, Santoro MG. Rossi A, et al. Biochem J. 1995 Jun 1;308 ( Pt 2)(Pt 2):455-63. doi: 10.1042/bj3080455. Biochem J. 1995. PMID: 7772027 Free PMC article.
• Purification and characterization of a fatty acid binding protein from human prostatic tissue.
  Chaudry AA, Dutta-Roy AK. Chaudry AA, et al. Lipids. 1993 May;28(5):383-8. doi: 10.1007/BF02535934. Lipids. 1993. PMID: 8316044
• Modulation of mitogenesis by liver fatty acid binding protein.
  Sorof S. Sorof S. Cancer Metastasis Rev. 1994 Dec;13(3-4):317-36. doi: 10.1007/BF00666102. Cancer Metastasis Rev. 1994. PMID: 7712594 Review.
• Impact of Intracellular Lipid Binding Proteins on Endogenous and Xenobiotic Ligand Metabolism and Disposition.
  Yabut KCB, Isoherranen N. Yabut KCB, et al. Drug Metab Dispos. 2023 Jun;51(6):700-717. doi: 10.1124/dmd.122.001010. Epub 2023 Apr 3. Drug Metab Dispos. 2023. PMID: 37012074 Free PMC article. Review.

References

1. 1. Prog Lipid Res. 1981;20:787-90 - PubMed
2. 1. Biochem Biophys Res Commun. 1986 Sep 14;139(2):808-15 - PubMed
3. 1. Experientia. 1990 Jun 15;46(6):617-30 - PubMed
4. 1. Biochem Biophys Res Commun. 1989 Jun 15;161(2):448-55 - PubMed
5. 1. Biochem J. 1976 Jun 1;155(3):511-21 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Atypon
  • Europe PubMed Central
  • PubMed Central

• Other Literature Sources

  • The Lens - Patent Citations Database

• Research Materials

  • NCI CPTC Antibody Characterization Program